MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales Of Cortrophin
Gel
$347,778K
Sales Of ILUVIENAnd
YUTIQ
$74,868K
Total Sales Of Rare
Disease Pharmaceutical...
$422,646K
Sales Of Established
Brands
$61,308K
Sales Of Generic
Pharmaceutical Products
$384,110K
Sales Of Royalties And
Other Pharmaceutical...
$15,302K
Total Sales Of Rare
Disease And Brands
$483,954K
Total Sales Of
Generics And Other
$399,412K
Net revenues
$883,366K
(43.78%↑ Y/Y)
Operating income
$111,093K
(18922.77%↑ Y/Y)
Unrealized gain on
investment in equity...
$2,824K
(-55.22%↓ Y/Y)
Other income
(expense), net
$1,934K
(147.95%↑ Y/Y)
Total operating
expenses, net
$772,273K
(25.82%↑ Y/Y)
Contingent consideration
fair value...
-$31,012K
(-4910.02%↓ Y/Y)
Income (loss) before
expense (benefit) for...
$95,791K
(531.26%↑ Y/Y)
Interest expense, net
-$20,060K
(-13.96%↓ Y/Y)
Cost of sales
(excluding depreciation...
$341,310K
(36.41%↑ Y/Y)
Selling, general, and
administrative
$317,745K
(27.28%↑ Y/Y)
Depreciation and
amortization
$91,417K
(34.97%↑ Y/Y)
Research and development
$51,664K
(15.89%↑ Y/Y)
Intangible asset
impairment charge
$767K
(-89.91%↓ Y/Y)
Loss (gain) on
disposal of assets
-$382K
Net income (loss)
$78,337K
(522.94%↑ Y/Y)
Income tax expense
(benefit)
$17,454K
(573.01%↑ Y/Y)
Net income (loss)
available to common...
$77,180K
(483.08%↑ Y/Y)
Dividends on series a
convertible preferred stock
$1,157K
(-28.80%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ANI PHARMACEUTICALS INC (ANIP)
ANI PHARMACEUTICALS INC (ANIP)